Cargando…
Identification of CD101 in Glioma: A Novel Prognostic Indicator Expressed on M2 Macrophages
Glioma represents the most common primary intracranial malignancy worldwide, with low overall survival rates and limited therapeutic options. The protein CD101, mainly expressed on several immune cells, has been demonstrated to exert potent effects on blunting T cell immune responses across infectio...
Autores principales: | Liu, Yuyang, Yao, Renqi, Shi, Ying, Liu, Yuxiao, Liu, Hongyu, Liu, Jialin, Guan, Yunqian, Yao, Yongming, Chen, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957828/ https://www.ncbi.nlm.nih.gov/pubmed/35350788 http://dx.doi.org/10.3389/fimmu.2022.845223 |
Ejemplares similares
-
Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas
por: Wang, Jinchao, et al.
Publicado: (2023) -
Differences of macrophages in the tumor microenvironment as an underlying key factor in glioma patients
por: Wang, Yangyang, et al.
Publicado: (2022) -
Integrated bioinformatics analysis and experimental validation reveal ISG20 as a novel prognostic indicator expressed on M2 macrophage in glioma
por: Peng, Yaojun, et al.
Publicado: (2023) -
MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients
por: Zhang, Chunyu, et al.
Publicado: (2022) -
Novel macrophage-related gene prognostic index for glioblastoma associated with M2 macrophages and T cell dysfunction
por: Ji, Hang, et al.
Publicado: (2022)